<html><head><link rel="stylesheet" type="text/css" href="usc.css"/><title>U.S.C. Title 21 - FOOD AND DRUGS</title></head><body>
<span style="font-weight:bold;font-size:12pt;">21 U.S.C. </span><br/>
<span style="font-size:10pt">United States Code, 1995 Edition</span><br/>
<span style="font-size:10pt">Title 21 - FOOD AND DRUGS</span><br/>
<span style="font-size:10pt">CHAPTER 8 - NARCOTIC FARMS</span><br/>
<span style="font-size:10pt">SUBCHAPTER V - DRUGS AND DEVICES</span><br/>
<span style="font-size:10pt">Part B - Drugs for Rare Diseases or Conditions</span><br/>
<span style="font-size:10pt">Sec. 360ee - Grants and contracts for development of drugs for rare diseases and conditions</span><br/>
<span style="font-size:10pt">From the U.S. Government Printing Office, <a href="http://www.gpo.gov">www.gpo.gov</a></span><br/><br/>
<!-- documentid:21_360ee  usckey:21000000003600000000000ee00000000 currentthrough:19960116 documentPDFPage:178 -->
<!-- itempath:/210/CHAPTER 8/SUBCHAPTER V/Part B/Sec. 360ee -->
<!-- itemsortkey:210AAIY -->
<!-- expcite:TITLE 21-FOOD AND DRUGS!@!CHAPTER 8-NARCOTIC FARMS!@!SUBCHAPTER V-DRUGS AND DEVICES!@!Part B-Drugs for Rare Diseases or Conditions!@!Sec. 360ee -->
<!-- field-start:head -->
<h3 class="section-head">&sect;360ee. Grants and contracts for development of drugs for rare diseases and conditions</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) Authority of Secretary</h4>
<p class="statutory-body">The Secretary may make grants to and enter into contracts with public and private entities and individuals to assist in (1) defraying the costs of qualified testing expenses incurred in connection with the development of drugs for rare diseases and conditions, (2) defraying the costs of developing medical devices for rare diseases or conditions, and (3) defraying the costs of developing medical foods for rare diseases or conditions.</p>
<h4 class="subsection-head">(b) Definitions</h4>
<p class="statutory-body">For purposes of subsection (a) of this section:</p>
<p class="statutory-body-1em">(1) The term &ldquo;qualified testing&rdquo; means&mdash;</p>
<p class="statutory-body-2em">(A) human clinical testing&mdash;</p>
<p class="statutory-body-3em">(i) which is carried out under an exemption for a drug for a rare disease or condition under section 355(i) of this title (or regulations issued under such section); and</p>
<p class="statutory-body-3em">(ii) which occurs after the date such drug is designated under section 360bb of this title and before the date on which an application with respect to such drug is submitted under section 355(b) or 357 of this title or under section 262 of title 42; and</p>
<br class="Q04" />
<p class="statutory-body-2em">(B) preclinical testing involving a drug for a rare disease or condition which occurs after the date such drug is designated under section 360bb of this title and before the date on which an application with respect to such drug is submitted under section 355(b) or 357 of this title or under section 262 of title 42.</p>
<br class="Q04" />
<p class="statutory-body-1em">(2) The term &ldquo;rare disease or condition&rdquo; means (1) in the case of a drug, any disease or condition which (A) affects less than 200,000 persons in the United States, or (B) affects more than 200,000 in the United States and for which there is no reasonable expectation that the cost of developing and making available in the United States a drug for such disease or condition will be recovered from sales in the United States of such drug, (2) in the case of a medical device, any disease or condition that occurs so infrequently in the United States that there is no reasonable expectation that a medical device for such disease or condition will be developed without assistance under subsection (a) of this section, and (3) in the case of a medical food, any disease or condition that occurs so infrequently in the United States that there is no reasonable expectation that a medical food for such disease or condition will be developed without assistance under subsection (a) of this section. Determinations under the preceding sentence with respect to any drug shall be made on the basis of the facts and circumstances as of the date the request for designation of the drug under section 360bb of this title is made.</p>
<p class="statutory-body-1em">(3) The term &ldquo;medical food&rdquo; means a food which is formulated to be consumed or administered enterally under the supervision of a physician and which is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation.</p>
<h4 class="subsection-head">(c) Authorization of appropriations</h4>
<p class="statutory-body">For grants and contracts under subsection (a) of this section there are authorized to be appropriated $10,000,000 for fiscal year 1988, $12,000,000 for fiscal year 1989,<sup><a href="#360ee_1_target" name="360ee_1">1</a></sup> $14,000,000 for fiscal year 1990.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(Pub. L. 97&ndash;414, &sect;5, Jan. 4, 1983, 96 Stat. 2056; Pub. L. 98&ndash;551, &sect;4(b), Oct. 30, 1984, 98 Stat. 2817; Pub. L. 99&ndash;91, &sect;5, Aug. 15, 1985, 99 Stat. 391; Pub. L. 100&ndash;290, &sect;3(a)&ndash;(c), Apr. 18, 1988, 102 Stat. 90, 91.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:codification-note -->
<h4 class="note-head">Codification</h4>
<p class="note-body">Section was enacted as part of the Orphan Drug Act, and not as part of the Federal Food, Drug, and Cosmetic Act which comprises this chapter.</p>
<!-- field-end:codification-note -->
<!-- field-start:amendment-note -->
<h4 class="note-head">Amendments</h4>
<p class="note-body">1988&mdash;Subsec. (a). Pub. L. 100&ndash;290, &sect;3(a)(1), (b)(1), inserted &ldquo;(1)&rdquo; after &ldquo;assist in&rdquo; and added cls. (2) and (3).</p>
<p class="note-body">Subsec. (b)(2). Pub. L. 100&ndash;290, &sect;3(a)(2), (b)(2), inserted &ldquo;(1) in the case of a drug,&rdquo; after &ldquo;means&rdquo;, added cls. (2) and (3), and substituted &ldquo;under section 360bb of this title&rdquo; for &ldquo;under this subsection&rdquo; in last sentence.</p>
<p class="note-body">Subsec. (b)(3). Pub. L. 100&ndash;290, &sect;3(b)(3), added par. (3).</p>
<p class="note-body">Subsec. (c). Pub. L. 100&ndash;290, &sect;3(c), amended subsec. (c) generally. Prior to amendment, subsec. (c) read as follows: &ldquo;For grants and contracts under subsection (a) of this section there are authorized to be appropriated $4,000,000 for fiscal year 1986, $4,000,000 for fiscal year 1987, and $4,000,000 for fiscal year 1988.&rdquo;</p>
<p class="note-body">1985&mdash;Subsec. (a). Pub. L. 99&ndash;91, &sect;5(a)(1), struck out &ldquo;clinical&rdquo; before &ldquo;testing&rdquo;.</p>
<p class="note-body">Subsec. (b)(1). Pub. L. 99&ndash;91, &sect;5(a)(2), substituted provisions defining &ldquo;qualified testing&rdquo; for provisions defining &ldquo;qualified clinical testing&rdquo;.</p>
<p class="note-body">Subsec. (c). Pub. L. 99&ndash;91, &sect;5(b), substituted provisions authorizing appropriations for fiscal years 1986 to 1988, for provisions authorizing appropriations for fiscal years 1983 and the two succeeding fiscal years.</p>
<p class="note-body">1984&mdash;Subsec. (b)(2). Pub. L. 98&ndash;551 substituted &ldquo;which (A) affects less than 200,000 persons in the United States, or (B) affects more than 200,000 in the United States and for which&rdquo; for &ldquo;which occurs so infrequently in the United States that&rdquo;.</p>
<!-- field-end:amendment-note -->
<!-- field-start:effectivedate-amendment-note -->
<h4 class="note-head">Effective Date of 1985 Amendment</h4>
<p class="note-body">Amendment by Pub. L. 99&ndash;91 effective Oct. 1, 1985, see section 8(a) of Pub. L. 99&ndash;91, set out as a note under section 360aa of this title.</p>
<!-- field-end:effectivedate-amendment-note -->
<!-- field-end:notes -->
<!-- field-start:secref -->
<h4 class="note-head">Section Referred to in Other Sections</h4>
<!-- field-end:secref -->
<!-- field-start:sectionreferredto -->
<p class="note-body">This section is referred to in section 343 of this title; title 42 section 236.</p>
<!-- field-end:sectionreferredto -->


</body></html>